This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nickoloff, B. J. Articles by Shimizu, Y. Search for Related Content PubMed PubMed Citation Articles by Nickoloff, B. J. Articles by Shimizu, Y.

American Journal of Pathology, Vol 142, 1029-1040, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo

BJ Nickoloff, RS Mitra, K Lee, LA Turka, J Green, C Thompson and Y Shimizu
Department of Pathology, University of Michigan, Ann Arbor.

The process for optimal T-cell activation requires not only engagement of the T-cell receptor/CD3 complex, but also the delivery of additional co-stimulatory signals that synergize with the primary response mediated through the T-cell receptor. Thus, the regulated expression of ligands for such co-stimulatory molecules can be critical in determining whether a cell can effectively activate T cells following the presentation of a foreign antigen. The CD28 antigen has recently been shown to mediate such co-stimulatory signals by interacting with the B7/BB-1 molecule expressed on activated B cells and monocytes. We show in this study that activated keratinocytes, both in vitro and in vivo display a discordance in expression between B7 and BB-1 based on differential monoclonal antibody (MAb) reactivity. Activated keratinocytes in vitro, as well as psoriatic keratinocytes and epithelial cells in the thymus, are reactive with the BB-1 MAb but not anti-B7 MAbs. These BB-1 positive cells fail to express detectable B7 messenger RNA by Northern blot analysis. Furthermore, keratinocytes bind specifically to CD28-transfected COS7 cells, and this binding is inhibited by anti-CD28 and anti-BB-1 but not B7 MAbs. These studies suggest: 1) that the MAb against BB-1 binds a functional epitope on a molecule distinct from B7 as detected on activated keratinocytes in vitro and in vivo and 2) that keratinocytes in skin and epithelial cells in thymus can express cell-surface molecules that might mediate T- cell co-stimulation via CD28.

This article has been cited by other articles:

				Z. Tatari-Calderone, R. T. Semnani, T. B. Nutman, J. Schlom, and H. Sabzevari Acquisition of CD80 by Human T Cells at Early Stages of Activation: Functional Involvement of CD80 Acquisition in T Cell to T Cell Interaction J. Immunol., December 1, 2002; 169(11): 6162 - 6169. [Abstract] [Full Text] [PDF]

				Z. Liu, K. Geboes, P. Hellings, P. Maerten, H. Heremans, P. Vandenberghe, L. Boon, P. van Kooten, P. Rutgeerts, and J. L. Ceuppens B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis J. Immunol., August 1, 2001; 167(3): 1830 - 1838. [Abstract] [Full Text] [PDF]

				H. Sabzevari, J. Kantor, A. Jaigirdar, Y. Tagaya, M. Naramura, J. W. Hodge, J. Bernon, and J. Schlom Acquisition of CD80 (B7-1) by T Cells J. Immunol., February 15, 2001; 166(4): 2505 - 2513. [Abstract] [Full Text] [PDF]

				G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation J. Exp. Med., October 2, 2000; 192(7): 1027 - 1034. [Abstract] [Full Text] [PDF]

				K.-y. Murata and M. C. Dalakas Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy Brain, August 1, 2000; 123(8): 1660 - 1666. [Abstract] [Full Text] [PDF]

				K.-y. Murata and M. C. Dalakas Expression of the Costimulatory Molecule BB-1, the Ligands CTLA-4 and CD28, and their mRNA in Inflammatory Myopathies Am. J. Pathol., August 1, 1999; 155(2): 453 - 460. [Abstract] [Full Text] [PDF]

				L. Behrens, M. Kerschensteiner, T. Misgeld, N. Goebels, H. Wekerle, and R. Hohlfeld Human Muscle Cells Express a Functional Costimulatory Molecule Distinct from B7.1 (CD80) and B7.2 (CD86) In Vitro and in Inflammatory Lesions J. Immunol., December 1, 1998; 161(11): 5943 - 5951. [Abstract] [Full Text] [PDF]

				G. J. Freeman, A. A. Cardoso, V. A. Boussiotis, A. Anumanthan, R. W. Groves, T. S. Kupper, E. A. Clark, and L. M. Nadler The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor J. Immunol., September 15, 1998; 161(6): 2708 - 2715. [Abstract] [Full Text] [PDF]

				G. Freeman, J. Gribben, V. Boussiotis, J. Ng, V. Restivo Jr, L. Lombard, G. Gray, and L. Nadler Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation Science, November 5, 1993; 262(5135): 909 - 911. [Abstract] [PDF]